MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/art.70312

Медицинская библиотека · Arthritis & rheumatology (Hoboken, N.J.) · 2026

Development and temporal validation of AI-enhanced HEp-2 indirect immunofluorescence image analysis for specific autoantibody prediction in systemic autoimmune rheumatic diseases.

Vanderboom Patrick, Dasari Surendra, Sandino-Bermúdez Marlon J, Tebo Anne, Snyder Melissa, Duarte-García Alí

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

ANA indirect immunofluorescence (IIF) is the reference standard but depends on subjective pattern interpretation. We tested whether artificial intelligence (AI) applied to ANA IIF images could identify specific autoantibodies.

METHODS

We assembled a cohort of ANA-positive patients (HEp-2 IIF titer ≥1:80) with anti-dsDNA, Sm, RNP, SSA, SSB, Scl-70, or centromere antibody (CMA) testing within 90 days. The development cohort (Dec 12, 2016-Dec 31, 2022) included the first ANA test per patient. Two AI architectures were trained for each autoantibody. Performance was assessed using area under the receiver operating characteristic curve (AUROC), sensitivity, specificity, and accuracy; comparisons with IIF patterns were summarized as pattern-antibody agreement. A prospective cohort (Jan 1, 2023-Aug 20, 2024), including a dsDNA assay transition, provided temporal validation.

RESULTS

Among 512,959 patients, 47,890 met inclusion criteria (mean age 55 [SD 17.6], 78% female). Models for CMA, dsDNA, Sm, SSA, and SSB achieved AUROC ≥0.80 (CMA highest: AUROC 0.95, accuracy 94.2%, specificity 95.3%). Compared with associated IIF patterns, dsDNA and Sm models more often classified antibody-negative cases as negative (dsDNA 88.2% vs 54.7%; Sm 82.6% vs 60.3%), while similarly classifying antibody-positive cases. Performance for RNP (AUROC 0.68) and Scl-70 (AUROC 0.59) was lower. In the prospective cohort (n=21,427), performance was similar; dsDNA discrimination remained stable across assays (AUROC ~0.85).

CONCLUSIONS

AI applied to ANA IIF images identified specific autoantibodies and often improved classification of antibody-negative cases versus simplified pattern-based comparators. These findings support its potential to standardize ANA interpretation and triage or reduce confirmatory testing.

Для цитирования: Vanderboom Patrick, Dasari Surendra, Sandino-Bermúdez Marlon J, Tebo Anne, Snyder Melissa, Duarte-García Alí. Development and temporal validation of AI-enhanced HEp-2 indirect immunofluorescence image analysis for specific autoantibody prediction in systemic autoimmune rheumatic diseases.. Arthritis & rheumatology (Hoboken, N.J.). 2026. DOI: 10.1002/art.70312.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.